Related Experiment Video
Updated: May 17, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Venous Thromboembolism Prophylaxis Compliance in Orthopedic Patients With Cardiac Risk Factors
Usama Asif1, Usman Ghani1, Sheikh Muhammad Rehman Zia2
1Internal Medicine, Aziz Bhatti Shaheed Teaching Hospital, Gujrat, PAK.
Abstract:
Introduction Venous thromboembolism (VTE) is a critical condition that includes deep vein thrombosis (DVT) and pulmonary embolism (PE), both of which can lead to severe complications, including death, if not adequately managed. Objective This study aimed to evaluate adherence to prophylactic measures and identify factors influencing compliance. Methodology This study was done in Shalamar Hospital, Lahore, from October 2023 to October 2024. Baseline assessments were conducted to gather demographic and clinical data, including age, gender, body mass index (BMI), comorbidities, and cardiac risk factors such as atrial fibrillation or coronary artery disease. Details of the surgical procedures, including type, duration, and anesthesia used, were also recorded. Compliance with VTE prophylaxis was monitored through patient interviews, direct observation, and medical record reviews. Pharmacological prophylaxis compliance involved evaluating the administration of anticoagulants regarding dosage, timing, and frequency. Mechanical prophylaxis adherence was assessed by monitoring the use of compression stockings and pneumatic devices. Compliance was measured as the percentage of patients who adhered to the prescribed prophylaxis protocols. Primary outcomes included the incidence of VTE events, such as DVT or PE, within 30 days post-surgery. Follow-ups were conducted through in-person visits or telephonic interactions to monitor compliance and postoperative outcomes. Data were analyzed using IBM SPSS Statistics for Windows, Version 26.0 (Released 2019; IBM Corp., Armonk, New York, United States). Continuous variables, such as age and BMI, were summarized using means and standard deviations, while categorical variables, like compliance rates, were expressed as frequencies and percentages. Subgroup analyses were conducted to identify variations in compliance rates based on demographic and clinical factors using t-tests. Results The study included 90 patients, with a mean age of 58.9±8.4 years and a nearly equal gender distribution (54% male and 46% female). The mean BMI of the participants was 28.5±3.2 kg/m². Hypertension was the most common cardiac risk factor, affecting 67% (n=60) of patients, followed by atrial fibrillation (22%; n=20) and heart failure (11%; n=10). Among the surgeries, 65% (n=58) were elective, while 35% (n=32) were emergency procedures. VTE incidence was 6.7% (n=6), with 4.4% (n=4) developing DVT and 2.2% (n=2) experiencing PE. Bleeding complications occurred in 8.9% (n=8) of patients, with 6.7% (n=6) experiencing minor bleeding and 2.2% (n=2) reporting major bleeding. Patients undergoing elective surgeries exhibited higher pharmacological compliance at 78% (n=45) and mechanical compliance at 88% (n=51), resulting in an overall compliance rate of 84% (n=49). In contrast, patients undergoing emergency surgeries had lower compliance rates, with 63% (n=20) for pharmacological prophylaxis and 69% (n=22) for mechanical prophylaxis, leading to an overall compliance rate of 63% (n=20). Conclusion It is concluded that compliance with VTE prophylaxis plays a pivotal role in reducing the risk of thromboembolic events in orthopedic patients with cardiac risk factors.
More Related Videos
08:05Occlusion of the Great and Small Saphenous Vein Using Copolymeric Glue Based on N-Butyl Cyanoacrylate and Methacryloxy Sulfolane
Published on: December 9, 2022
10:28Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Pre-Procedural Guidelines for Assessing Blood Pressure
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Assessment of the Cardiovascular System III: Palpation
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above...
Cardiovascular Drugs: Classification based on Therapeutic Indications